News & Articles

The kits aim to detect traces of SARS-CoV-2 virus on surfaces such as plastics, ceramics and stainless steel

Enables labs to quickly ramp up testing capacity and generate results faster

Join us on Thursday, September 10, to learn how the Mosquito HV liquid handler can help in obtaining single-cell RNA data

Dr. Jeremy Hirota takes us through the technology behind his translational research program for respiratory health

Join us on Tuesday, August 18, to learn about the methods used for profiling RNA in COVID-19 samples

Just leave a quick lab product review today for your chance to scoop one of our weekly $100 prizes

Find out how collaboration between Pall and key life sciences researchers is helping to innovate and accelerate biologic development

Learn how RNAscope technology was adapted to study plant tissues and gain insights into plant immunity

Promega automated sample preparation solution added to CDC COVID-19 test protocol

Learn about sample contaminant detection, an important step towards nucleic acid quantification

This on-demand webinar shows how to simplify your nucleic acid extraction, limit operator-dependent variation, and improve the traceability of your workflows

The partnership aims to provide accessible solutions for labs involved in COVID-19 testing

Key topics to include COVID-19 and infectious diseases, diabetes, sepsis, cardiovascular disease and personalized medicine as the global clinical community comes together to make the future healthier

The partnership aims to accelerate the commercialization of enzymatic DNA synthesis

Designed by scientists for scientists, FaSTR DNA expedites the analysis of raw data generated by genetic analyzers and standard profiling kits

Our new expert webinar series aims to help you get the most from your microbiology research

Don’t miss this on-demand webinar exploring how RNAscope technology can be used to detect viral infection and pathogenesis

Clinical researchers are this week set to begin human trials of a new coronavirus vaccine developed by researchers at Imperial College London

Novel platform initially focussed on high-resolution industrial scale processing of therapeutic mRNA